Isoniazid Induced Cutaneous Leukocytoclastic Vasculitis in Extra Pulmonary Tuberculosis (Pott's Spine): A Case Report

被引:5
|
作者
Bondalapati, Sowmya [1 ]
Rao, Dharma, V [1 ]
Rampure, Dilip [1 ]
Rao, Rama S. [1 ]
机构
[1] Mamata Med Coll, Dept Gen Med, Khammam, Andhra Pradesh, India
关键词
Anti tuberculosis drugs; Isoniazid; Leucocytoclastic vasculitis; Pott's spine;
D O I
10.7860/JCDR/2014/9000.4688
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anti-tuberculosis drugs frequently result in cutaneous adverse reactions but Isoniazid is known to have least toxic potential for cutaneous reactions. We report a rare case of Isoniazid induced cutaneous leucocytoclastic vasculitis. A 64-year-old male was diagnosed to have Pott's spine with multiple vertebral body involvement (D8-12 vertebrae). Subsequently, he was treated with first line anti-TB drugs i. e., Isoniazid, Rifampicin, Pyrazinamide and Ethambutol. On the fourth day of treatment with Anti Tuberculosis Treatment (ATT), the patient developed an erythematosus rash over right upper limb not associated with itching or pain, non-blanchable macules and papules over bilateral shins on lower limbs, petechiae on both forearms and hyper pigmented, scaly rash over right axilla and buttocks. The skin biopsy report was consistent with cutaneous leukocytoclastic vasculitis. Although rare, Isoniazid among anti-tuberculosis drugs should be considered as potential cause of drug-induced cutaneous leukocytoclastic vasculitis in the differential diagnosis of erythematosus rash with petechiae.
引用
收藏
页码:MD3 / MD5
页数:3
相关论文
共 50 条
  • [31] Isoniazid Induced Toxic Epidermal Necrolysis in a HIV Positive Patient during Treatment for Extra Pulmonary Tuberculosis: A Case Report
    Muthaiah, Bhanukumar
    Panachiyil, George Mathew
    Babu, Tirin
    Harshavardhini, Allu
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (03) : OD16 - OD17
  • [32] Carbimazole-induced leukocytoclastic vasculitis: a case report.
    Yazbeck, R
    Francoual, J
    Benoit, P
    Tauveron, I
    Tchen, C
    Thieblot, P
    REVUE DE MEDECINE INTERNE, 1999, 20 (04): : 350 - 352
  • [33] Daclatasvir and sofosbuvir-induced cutaneous adverse reaction with leukocytoclastic vasculitis lesions: first case report
    Dautriche, A.
    Minello, A.
    Cosme, H.
    Jeudy, G.
    Leleu, C.
    Aubriot-Lorton, M. H.
    Grandvuillemin, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 54 - 54
  • [34] Psoas Abscess with Pott’s Spine: A Case Report
    Evangeline Gladwin
    Rudra Patel
    Vaishnavi Patel
    Mrudangsinh Rathod
    SN Comprehensive Clinical Medicine, 6 (1)
  • [35] Leukocytoclastic Vasculitis Caused by Disseminated Cutaneous Sporotrichosis: A Case Report and Review of the Literature
    Shi, Ying
    Yu, Yan
    Li, Shan-Shan
    Cui, Yan
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2022, 44 (03) : 223 - 225
  • [36] Vancomycin-Induced Leukocytoclastic Vasculitis: A Rare Case Report
    Sharma, Pratibha
    Sharma, Eliza
    Neupane, Sanjay P.
    Dahal, Suyash
    Dahal, Sumit
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2018, 6
  • [37] Cutaneous leukocytoclastic vasculitis associated with erlotinib treatment: A case report and review of the literature
    Fekete, Gyula Laszlo
    Fekete, Laszlo
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (02) : 1128 - 1131
  • [38] Squamous cell carcinoma of the lung presenting with cutaneous leukocytoclastic vasculitis - A case report
    Odeh, M
    Misselevich, I
    Oliven, A
    ANGIOLOGY, 2001, 52 (09) : 641 - 644
  • [39] Dengue associated with severe cutaneous leukocytoclastic vasculitis and pericardial effusion: a case report
    da Costa, Laurisson Albuquerque
    Santos, Eduardo Feitosa
    Bezerra Araujo Feitoza, Erielly Maria
    Yamashita, Miyuki
    Andrade, Joyce Cabral
    Leite de Sousa, Pedro Vinicius
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2020, 62 : e101
  • [40] Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection: A case report
    Iraji, Fariba
    Galehdari, Hamid
    Siadat, Amir Hossein
    Jazi, Safoura Bokaei
    CLINICAL CASE REPORTS, 2021, 9 (02): : 830 - 834